NEW YORK, April 30 - Aclara BioSciences of Mountain View, Calif., said today that it is expanding its eTag assay collaboration with Genentech.
The expansion of the collaboration, initiated in 2002, includes additional milestone fees payable by Genentech. Further details were not provided.
Aclara said the expansion follows the successful achievement of an initial milestone, the design of a customized eTag essay to measure specific receptor binding and signaling. The eTag system uses Aclara's eTag reporters for multiplex gene or protein analysis in a single sample.
Earlier this week, Aclara announced 30 additional worker layoffs to the 50 workers fired in a restructuring that began in July. The company also hired a new chief business officer, and appointed a new member to its board of directors.